Impact of Chemotherapy Educational Videos for Patients with Acute Myeloid Leukemia

被引:0
|
作者
Gabbard, Taylor [1 ,2 ]
Perissinotti, Anthony J. [1 ,2 ]
Benitez, Lydia L. [1 ,2 ]
Fraga, Martina [1 ,2 ]
Pettit, Kristen M. [3 ]
Bixby, Dale L. [3 ]
Burke, Patrick W. [3 ]
Marini, Bernard L. [1 ,2 ]
机构
[1] Michigan Med, Dept Clin Pharm, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Med Sch, Ann Arbor, MI USA
关键词
AML; Patient education; Video;
D O I
10.1007/s13187-024-02473-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patient education in acute myeloid leukemia (AML) has become increasingly complex with the introduction of new treatments and chemotherapy regimens. Video education presents an opportunity to supplement traditional patient education and address some of the gaps associated with standard methods. This single-center study sought to assess the potential impact of supplemental video education on patients receiving induction chemotherapy for AML. Participants were consented to be randomized to receive their education with or without a supplemental video designed for their treatment regimen. We then provided a survey to each participant to assess knowledge retention, anxiety, and overall satisfaction with their care. Patients that received video education were found to have significantly improved knowledge retention compared to those that did not. There were no differences detected in anxiety or patient satisfaction. Video education appears to be an effective supplemental method for patient education in AML. Limitations include the single-center nature of the study at an urban academic medical center with a relatively well-educated, primarily Caucasian, younger population. Future research is warranted to assess the video in a diverse set of languages and to explore its broader benefits.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [1] COMPARISON OF THE EFFECTIVENESS OF SUPPORTIVE CHEMOTHERAPY FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Bessmertnyy, D. K.
    Lukyanova, I. A.
    Troitskaya, V. V.
    Fidarova, Z. T.
    Kashlakova, A. I.
    Kulikov, S. M.
    Afanasov, A. O.
    Parovichnikova, E. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2024, 69 (03): : 285 - 295
  • [2] Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia
    Ciftciler, Rafiye
    Demiroglu, Haluk
    Haznedaroglu, Ibrahim Celalettin
    Sayinalp, Nilgun
    Aksu, Salih
    Ozcebe, Osman
    Goker, Hakan
    Aydin, Muruvvet Seda
    Buyukasik, Yahya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (11) : 729 - 734
  • [3] Impact of FLT3-ITD diversity on response to induction chemotherapy in patients with acute myeloid leukemia
    Fischer, Mike
    Schnetzke, Ulf
    Spies-Weisshart, Baerbel
    Walther, Mario
    Fleischmann, Maximilian
    Hilgendorf, Inken
    Hochhaus, Andreas
    Scholl, Sebastian
    HAEMATOLOGICA, 2017, 102 (04) : E129 - E131
  • [4] HOTAIR expression and prognostic impact in acute myeloid leukemia patients
    Rawda Ahmed Alaaeldin Ahmed Mohamed Saad
    Amany Ahmed Osman
    Mona Fathey Abdel Fattah Hassan
    Shereen Abdel Monem Ibrahim
    Yasmin Nabil El-Sakhawy
    Egyptian Journal of Medical Human Genetics, 22
  • [5] HOTAIR expression and prognostic impact in acute myeloid leukemia patients
    Eldin, Rawda Ahmed Alaa
    Osman, Amany Ahmed
    Hassan, Mona Fathey Abdel Fattah
    Ibrahim, Shereen Abdel Monem
    El-Sakhawy, Yasmin Nabil
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2021, 22 (01)
  • [6] Novel Translocation in Acute Myeloid Leukemia: Case Report and Review of Risk-Stratification and Induction Chemotherapy in Patients With Acute Myeloid Leukemia
    Jeha, George M.
    Wesley, Tiffany
    Cataldo, Vince D.
    JOURNAL OF HEMATOLOGY, 2020, 9 (1-2) : 13 - 17
  • [7] Intensively Timed Combination Chemotherapy for the Induction of Adult Patients With Acute Myeloid Leukemia
    Rytting, Michael
    Ravandi, Farhad
    Estey, Elihu
    Cortes, Jorge
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Jeha, Sima
    Ouzounian, Souzanne
    Pierce, Sherry
    Kantarjian, Hagop
    CANCER, 2010, 116 (22) : 5272 - 5278
  • [8] FCHSD2 predicts response to chemotherapy in acute myeloid leukemia patients
    Han, Youqi
    Cui, Jie
    Lu, Yan
    Sue, Stephanie
    Arpaia, Enrico
    Mak, Tak W.
    Minden, Mark D.
    LEUKEMIA RESEARCH, 2012, 36 (11) : 1339 - 1346
  • [9] Persistent cytogenetic abnormalities in patients undergoing intensive chemotherapy for acute myeloid leukemia
    Saini, Lalit
    Brandwein, Joseph
    Szkotak, Artur
    Ghosh, Sunita
    Sandhu, Irwindeep
    LEUKEMIA & LYMPHOMA, 2018, 59 (01) : 121 - 128
  • [10] Impact of Genetic Alterations and Types of Chemotherapy on Outcomes of Patients with Extramedullary Acute Myeloid Leukemia and Myeloid Sarcoma: A Single-Center Experience
    Shatilova, Aleksina
    Girshova, Larisa
    Zaytsev, Daniil
    Budaeva, Irina
    Mirolyubova, Yuliya
    Ryzhkova, Darya
    Grozov, Roman
    Bogdanov, Konstantin
    Nikulina, Tatiana
    Motorin, Dmitriy
    Zammoeva, Darina
    Efremova, Svetlana
    Ivanov, Vladimir
    Petukhov, Alexey
    Osipov, Yury
    Alekseeva, Yuliya
    Zaritskey, Andrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S280 - S281